Applied Clinical Research, Clinical Trials and Regulatory Affairs is an international journal with market leadership in readership and contributions that are scientific, original, relevant, innovative and statistically validated. The journal aims to further bridge the gap in the publication of clinical drug development and regulatory affairs between high growth and potentially growing regions.
The journal Applied Clinical Research, Clinical Trials and Regulatory Affairs publishes innovative, developmental and original research on validated experimental design, methods, representation and interpretation of clinical research and drug trials. Additionally, the journal publishes original research articles, full-length/mini reviews, short communications and thematic journal issues. Published work is based on solid clinical, scientific and statistically relevant results that lead to advancements in clinical medicine including nanomedicine, clinical research, clinical devices, biomedical engineering related to clinical medicine, regulatory affairs and human subject protection in the areas of biological advances, drugs, bio-therapeutics and devices.
Anti-carbamylated Protein Antibodies and Serum Level of 14-3-3 Protein for Early Detection of Rheumatoid Arthritis Patient in Correlation with Rheumatoid Factor, Anti-CCP Antibodies, Disease Activity and Joint Damage using High Frequency Musculoskeletal Ultrasound
Inga Harks, Dag Harmsen, Martina Gravemeier, Karola Prior, Raphael Koch, Stephan Doering, Gregor Petersilka, Thomas Weniger, Peter Eickholz, Thomas Hoffmann, Ti-Sun Kim, Thomas Kocher, Jorg Meyle, Peter Purucker, Ulrich Schlagenhauf and Benjamin Ehmke